0 Comments
0 Shares
445 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Alpha-1 Antitrypsin Deficiency Treatment Market Growth Supported by Oxygen Therapy and Liver Transplantation ProceduresThe Type 1 Alpha-1 Antitrypsin Deficiency Treatment market, a rare genetic disorder in which the body produces insufficient alpha-1 antitrypsin protein leading to lung and liver damage is growing steadily. The market growth is driven by increasing disease awareness, improved diagnostic screening, the launch of new therapies (including augmentation therapies, gene therapies, RNA-based...0 Comments 0 Shares 459 Views 0 Reviews
-
Anti-GPC3 Innovations Transforming Liver Cancer CareThe Anti-GPC3 Targeted Therapies Market is emerging as a dynamic segment within oncology, focused on precision treatments that target glypican-3 (GPC3)—a cell surface protein prominently expressed in hepatocellular carcinoma (HCC) and several solid tumors. As global liver cancer rates continue to grow, particularly in regions with high hepatitis B and C prevalence, GPC3-based therapies...0 Comments 0 Shares 175 Views 0 Reviews
-
Choline, Liver Health & Why Many Adults Aren’t Getting EnoughMost people don’t realise that choline is essential for liver function — and that inadequate intake can lead to fat accumulation in the liver within weeks. A comprehensive review published in Nutrients (2018) highlights how choline deficiency contributes to fatty liver, impaired lipid transport, and muscle damage. Study link: https://www.mdpi.com/2072-6643/10/10/1513...0 Comments 0 Shares 297 Views 0 Reviews
-
Cod Liver Oil Market Outlook | Share, Growth & Key PlayersWhat is the projected growth rate (CAGR) of the Cod Liver Oil Market from 2024 to 2031, and what is the market value expected to change by 2031? Cod Liver Oil Market growing at a CAGR of 8.56% during the forecast period (2023-2030). Unlock exclusive insights with our detailed sample report : https://www.datamintelligence.com/download-sample/cod-liver-oil-market What is the Cod Liver Oil...0 Comments 0 Shares 735 Views 0 Reviews
-
How MASH is Shaping the Future of Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis (MASH), formerly known as Non-Alcoholic Steatohepatitis (NASH), is quickly emerging as a major global health concern. Closely linked to metabolic conditions such as obesity, type 2 diabetes, and insulin resistance, MASH represents a progressive form of fatty liver disease that can lead to serious complications like liver cirrhosis, failure, or...0 Comments 0 Shares 2K Views 0 Reviews
-
Latest Treatment Approaches in Advanced Liver CancerHepatocellular carcinoma (HCC) is the most common form of primary liver cancer and represents a significant global health burden. Accounting for nearly 90% of all primary liver malignancies, HCC typically arises in the setting of chronic liver disease and cirrhosis. The global incidence is increasing, particularly in regions with high rates of hepatitis B and C, alcoholic liver disease, and...0 Comments 0 Shares 2K Views 0 Reviews
-
Liver Cancer Drug Market Size, Growth and forecastLiver cancer drugs are medications specifically developed to treat cancerous growths in the liver by destroying or controlling malignant cells while aiming to preserve healthy tissue. These therapies work through different mechanisms such as blocking cancer cell growth, enhancing immune response, or directly targeting tumor pathways. The term encompasses a wide range of treatments, including...0 Comments 0 Shares 461 Views 0 Reviews
-
Liver Cancer Treatment Market Outlook: Key Players and Regional InsightsWhat is the projected growth rate (CAGR) of the Liver Cancer Treatment Market from 2025 to 2033, and what is the market value expected to change by 2033? The Global Liver Cancer Treatment Market size reached US$4.58 billion in 2024 and is expected to reach US$12.88 billion by 2033, growing at a CAGR of 11.4% during the forecast period 2025-2033. What is Liver Cancer Treatment Market? Liver...0 Comments 0 Shares 2K Views 0 Reviews
-
Liver Cancer Treatment Market Poised for 11.4% CAGR Surge, Driven by Immunotherapies and Targeted TherapiesThe global liver cancer treatment market was valued at US$ 4.58 billion in 2024 and is projected to reach US$ 12.88 billion by 2033, registering a CAGR of 11.4% from 2025 to 2033. The market is expanding steadily due to the rising global incidence of liver cancer, largely driven by risk factors such as hepatitis B and C infections, alcohol consumption, obesity, and non-alcoholic fatty liver...0 Comments 0 Shares 605 Views 0 Reviews
-
Can Moringa Help Manage Blood Sugar Naturally? New Research Says YesA new clinical trial published in Nutrients has spotlighted Moringa oleifera, a nutrient-dense plant long used in traditional medicine, for its potential to help manage blood sugar in people with prediabetes. 🌿 What Is Moringa? Moringa oleifera — also called the “drumstick tree” — is rich in polyphenols, vitamins, minerals, and plant-based antioxidants. Its leaves...0 Comments 0 Shares 676 Views 0 Reviews
-
Patient Awareness and Its Role in Europe Liver Disease Treatment GrowthThe Europe liver disease treatment market is experiencing substantial growth driven by increasing prevalence of chronic liver disorders, such as hepatitis, cirrhosis, and non-alcoholic fatty liver disease (NAFLD). Rising healthcare awareness, improvements in diagnostic infrastructure, and innovations in therapeutic approaches are fueling demand across the region. According to DataM...0 Comments 0 Shares 392 Views 0 Reviews
-
Precision Medicine and Immunotherapy Redraw Liver Cancer Treatment LandscapeLiver Cancer Therapeutics Market Set to Surge Beyond $15.7 Billion by 2032 on Innovation and Global Demand The Liver Cancer Therapeutics Market is entering a pivotal period of rapid growth. Projected to rise from approximately USD 3.1 billion in 2023 to USD 15.7 billion by 2032, the sector is experiencing a compound annual growth rate (CAGR) of nearly 7.9%. Some forecasts predict even faster...0 Comments 0 Shares 2K Views 0 Reviews
-
U.S. Dominates Global MASH Therapy Landscape with 43% Market ShareThe North America Metabolic Dysfunction–Associated Steatohepatitis (MASH) Treatment Market is witnessing exponential growth, rising from USD 3.70 billion in 2024 to an anticipated USD 17.15 billion by 2033, at a strong compound annual growth rate (CAGR) of 19.3% from 2025 to 2033. This dynamic expansion is fueled by the increasing prevalence of obesity, Type 2 diabetes, aging population,...0 Comments 0 Shares 2K Views 0 Reviews
More Results
Sponsored
Sponsored
Arabic
עברית
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek